- Home
- MOBX vs CCEL Comparison
MOBX vs CCEL Comparison
Compare MOBX & CCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MOBX
- CCEL
- Stock Information
- Founded
- MOBX 2020
- CCEL 1989
- Country
- MOBX United States
- CCEL United States
- Employees
- MOBX N/A
- CCEL N/A
- Industry
- MOBX
- CCEL Managed Health Care
- Sector
- MOBX
- CCEL Health Care
- Exchange
- MOBX Nasdaq
- CCEL Nasdaq
- Market Cap
- MOBX 34.2M
- CCEL 39.9M
- IPO Year
- MOBX N/A
- CCEL 1997
- Fundamental
- Price
- MOBX $0.85
- CCEL $4.83
- Analyst Decision
- MOBX
- CCEL Strong Buy
- Analyst Count
- MOBX 0
- CCEL 1
- Target Price
- MOBX N/A
- CCEL $8.50
- AVG Volume (30 Days)
- MOBX 245.3K
- CCEL 13.2K
- Earning Date
- MOBX 08-13-2025
- CCEL 07-22-2025
- Dividend Yield
- MOBX N/A
- CCEL 20.62%
- EPS Growth
- MOBX N/A
- CCEL N/A
- EPS
- MOBX N/A
- CCEL 0.01
- Revenue
- MOBX $10,692,000.00
- CCEL $32,102,750.00
- Revenue This Year
- MOBX N/A
- CCEL $2.49
- Revenue Next Year
- MOBX N/A
- CCEL $0.95
- P/E Ratio
- MOBX N/A
- CCEL $301.41
- Revenue Growth
- MOBX 450.28
- CCEL 2.33
- 52 Week Low
- MOBX $0.55
- CCEL $4.75
- 52 Week High
- MOBX $2.47
- CCEL $9.43
- Technical
- Relative Strength Index (RSI)
- MOBX 64.11
- CCEL 40.85
- Support Level
- MOBX $0.72
- CCEL $4.80
- Resistance Level
- MOBX $0.84
- CCEL $6.35
- Average True Range (ATR)
- MOBX 0.06
- CCEL 0.26
- MACD
- MOBX 0.01
- CCEL -0.03
- Stochastic Oscillator
- MOBX 89.32
- CCEL 2.08
About MOBX Mobix Labs Inc.
Mobix Labs Inc. specializes in designing, developing, and selling components and systems for wireless and wired connectivity, radio frequency (RF) technologies, switching, and electromagnetic interference (EMI) filtering solutions. The company serves markets, including commercial, industrial, automotive, medical, aerospace, defense, and others.
About CCEL Cryo-Cell International Inc.
Cryo-Cell International Inc is engaged in cellular processing and cryogenic storage. The company is organized into three reportable segments namely cellular processing and cryogenic storage, with a focus on the collection and preservation of umbilical cord blood and tissue stem cells for family use and the manufacturing of PrepaCyte CB units segment, which is a processing technology used to process umbilical cord blood stem cells. The Public cord blood banking segment consists of cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. The company generates maximum revenue from Cellular processing and Cryogenic storage and it derives revenue from processing and testing fees and Storage segment.